Russia's Second Vaccine "100% Effective" In Early-Stage Trials: Report

A candidate COVID-19 vaccine known as EpiVacCorona, Russia's second to be registered, proved "100% effective" in early-stage trials, Russian consumer health watchdog Rospotrebnadzor has told local...

https://ift.tt/eA8V8J